Bank of New York Mellon Corp - KALOBIOS PHARMACEUTICALS INC ownership

KALOBIOS PHARMACEUTICALS INC's ticker is KBIO and the CUSIP is 48344T100. A total of 46 filers reported holding KALOBIOS PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of KALOBIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2014$76,000
-26.9%
28,064
+18.6%
0.00%
Q4 2013$104,000
-47.5%
23,664
-46.1%
0.00%
Q3 2013$198,000
+58.4%
43,890
+99.0%
0.00%
Q2 2013$125,00022,0520.00%
Other shareholders
KALOBIOS PHARMACEUTICALS INC shareholders Q4 2013
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 2,632,928$11,638,0003.76%
Opaleye Management Inc. 285,000$1,168,500,0000.92%
SPHERA FUNDS MANAGEMENT LTD. 385,000$1,702,0000.47%
Lehman Brothers Holdings Inc. 657,442$2,906,0000.28%
WALL STREET ASSOCIATES 625,200$2,763,0000.23%
Old West Investment Management, LLC 56,925$251,0000.15%
WEXFORD CAPITAL LP 307,820$1,361,0000.12%
CLOUGH CAPITAL PARTNERS L P 397,400$1,757,0000.06%
PRIMECAP MANAGEMENT CO/CA/ 4,699,975$20,774,0000.02%
SABBY MANAGEMENT, LLC 80,650$356,0000.02%
View complete list of KALOBIOS PHARMACEUTICALS INC shareholders